Assessing availability, prices, and market share of quality-assured malaria ACT and RDT in the private retail sector in Nigeria and Uganda
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Background: An estimated 50% of suspected malaria cases in sub-Saharan Africa first seek care in the private sector, especially in private medicine retail outlets. Quality of care in these outlets is generally unknown but considered poor with many patients not receiving a confirmatory diagnosis or the recommended first-line artemisinin-based combination therapy (ACT). In 2010, a subsidy pilot scheme, the Affordable Medicines Facility malaria, was introduced to crowd out the use of monotherapies in favour of WHO-pre-qualified artemisinin-based combinations (WHO-PQ-ACTs) in the private health sector. The scheme improved the availability, market share, and cost of WHO-PQ-ACTs in countries like Nigeria and Uganda, but in 2018, the subsidies were halted in Nigeria and significantly reduced in Uganda. This paper presents findings from six retail audit surveys conducted from 2014 to 2021 in Nigeria and Uganda to assess whether the impact of subsidies on the price, availability, and market share of artemisinin-based combinations has been sustained after the subsidies were reduced or discontinued. Methods: Six independent retail audits were conducted in private medicine retail outlets, including pharmacies, drug shops, and clinics in Nigeria (2016, 2018, 2021), and Uganda (2014, 2019, 2020) to assess the availability, price, and market share of anti-malarials, including WHO-PQ-ACTs and non-WHO-PQ-ACTs, and malaria rapid diagnostic tests (RDTs). Results: Between 2016 and 2021, there was a 57% decrease in WHO-PQ-ACT availability in Nigeria and a 9% decrease in Uganda. During the same period, non-WHO-PQ-ACT availability increased in Nigeria by 41% and by 34% in Uganda. The price of WHO-PQ-ACTs increased by 42% in Nigeria to $0.68 and increased in Uganda by 24% to $0.95. The price of non-WHO-PQ-ACTs decreased in Nigeria by 26% to $1.08 and decreased in Uganda by 64% to $1.23. There was a 76% decrease in the market share of WHO-PQ-ACTs in Nigeria and a 17% decrease in Uganda. Malaria RDT availability remained low throughout. Conclusion: With the reduction or termination of subsidies for WHO-PQ-ACTs in Uganda and Nigeria, retail prices have increased, and retail prices of non-WHO-PQ-ACTs decreased, likely contributing to a shift of higher availability and increased use of non-WHO-PQ-ACTs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A recent study found that following the reduction or termination of subsidies for d ACTs in Uganda and Nigeria, retail prices of these medicines increased and retail prices of non-quality assured ACTs decreased.168”
From Global health 2050: the path to halving premature death by mid-century (2024) · cites this paper as [168]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman, C., Kachur, S. P., Abdulla, S., Bloland, P., & Mills, A. (2007) · Health Policy and Planning · doi:10.1093/heapol/czm033 · Cited by 178
O'Connell, K. A., Gatakaa, H., Poyer, S., Njogu, J., Evance, I., Munroe, E., Solomon, T., Goodman, C., Hanson, K., Zinsou, C., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-326 · Cited by 159
Littrell, M., Gatakaa, H., Evance, I., Poyer, S., Njogu, J., Solomon, T., Munroe, E., Chapman, S., Goodman, C., Hanson, K., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-327 · Cited by 138
Sabot, O. J., Mwita, A., Cohen, J. M., Ipuge, Y., Gordon, M., Bishop, D., Odhiambo, M., Ward, L., & Goodman, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006857 · Cited by 105 · cited 1×
“…and uptake of ACT in the private sector, low-cost arte-misinin-based combinations were introduced in the private sector through an ex-factory subsidy scheme implemented in nine malaria-endemic countries: Cam-bodia, Ghana, Kenya, Madagascar, Niger, Nigeria, Tanzania, Uganda, Zanzibar [11, 12].”
Bruxvoort, K. J., Leurent, B., Chandler, C., Ansah, E., Baiden, F., Björkman, A., Burchett, H., Clarke, S. E., Cundill, B., DiLiberto, D., et al. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0955 · Cited by 85
Kangwana, B. P., Kedenge, S. V., Noor, A. M., Alegana, V. A., Nyandigisi, A. J., Pandit, J., Fegan, G. W., Todd, J. E., Brooker, S., Snow, R. W., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000437 · Cited by 83
Odaga, J., Sinclair, D., Lokong, J. A., Donegan, S., Hopkins, H., & Garner, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008998.pub2 · Cited by 79
Bennett, A. F., Avanceña, A. L. V., Wegbreit, J., Cotter, C., Roberts, K. W., & Gosling, R. D. (2017) · Malaria Journal · doi:10.1186/s12936-017-1901-1 · Cited by 78
The feasibility of introducing rapid diagnostic tests for malaria in drug shops in Uganda
Mbonye, A. K., Ndyomugyenyi, R., Turinde, A., Magnussen, P., Clarke, S. E., & Chandler, C. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-367 · Cited by 69
Optimizing Investments in Malaria Treatment and Diagnosis
Cohen, J. M., Woolsey, A. M., Sabot, O. J., Gething, P. W., Tatem, A. J., & Moonen, B. (2012) · Science · doi:10.1126/science.1229045 · Cited by 67
Self-citationMbonye, A. K., Lal, S. D., Cundill, B., Hansen, K. S., Clarke, S. E., & Magnussen, P. (2013) · Malaria Journal · doi:10.1186/1475-2875-12-131 · Cited by 64
ACTwatch Group, Tougher, S., Hanson, K., & Goodman, C. (2017) · Malaria Journal · doi:10.1186/s12936-017-1814-z · Cited by 60
Kachur, S. P., Black, C. M., Abdulla, S., & Goodman, C. A. (2006) · Malaria Journal · doi:10.1186/1475-2875-5-25 · Cited by 50
Maloney, K. H., Ward, A., Krenz, B., Petty, N., Bryson, L., Dolkart, C., Visser, T., Menach, A. L., Scott, V. K., Cohen, J. M., et al. (2017) · Malaria Journal · doi:10.1186/s12936-016-1658-y · Cited by 50
Self-citationACTwatch Group, Musuva, A., Ejersa, W., Kiptui, R., Memusi, D. N., & Abwao, E. (2017) · Malaria Journal · doi:10.1186/s12936-017-2089-0 · Cited by 46
Briggs, M. A., Kalolella, A., Bruxvoort, K., Wiegand, R., Lopez, G., Festo, C., Lyaruu, P., Kenani, M., Abdulla, S., Goodman, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094074 · Cited by 45
Price subsidies increase the use of private sector ACTs: evidence from a systematic review
Morris, A., Ward, A., Moonen, B., Sabot, O. J., & Cohen, J. M. (2014) · Health Policy and Planning · doi:10.1093/heapol/czu013 · Cited by 44
Self-citationNwokolo, E., Ujuju, C. N., Anyanti, J., Isiguzo, C., Udoye, I., Bongos-Ikwue, E., Ezire, O., Raji, M., & Oyibo, W. A. (2017) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2017.122 · Cited by 38
ACTwatchGroup, T., Willey, B., Tougher, S., Yé, Y., Mann, A. G., Thomson, R. M., Kourguéni, I. A., Amuasi, J., Ren, R., Wamukoya, M., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-46 · Cited by 36
Larson, B. A., Amin, A. A., Noor, A. M., Zurovac, D., & Snow, R. W. (2006) · BMC Public Health · doi:10.1186/1471-2458-6-314 · Cited by 27
Edwards, H. M., Sarwar, R., Mahmud, P., Emmanuel, S., Maxwell, K., & Tibenderana, J. (2022) · Malaria Journal · doi:10.1186/s12936-021-04039-9 · Cited by 21
Research works printed but not linked: 1
- Oladosu OO, Oyibo WA, Bachani D, Hazir T, Ramharter M, Remoue F, et al. Overdiagnosis and overtreatment of malaria in children that presented with fever in Lagos. Nigeria ISRN Infect Dis. 2013;2013: 914675.
Cited by
Global health 2050: the path to halving premature death by mid-century
Jamison, D. T., Summers, L. H., Chang, A. Y., Karlsson, O., Mao, W., Norheim, O. F., Ogbuoji, O., Schäferhoff, M., Watkins, D., Adeyi, O., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01439-9 · Cited by 125
Luekveerawattana, R. (2025) · Cogent Social Sciences · doi:10.1080/23311886.2025.2458066 · Cited by 21
The 24, 2 hours initiative: a game changer in malaria mortality reduction
Ranjbar, M., Katureebe, C., Musanhu, C., Maureen, A., Nabakooza, J., Rukundo, G. B., Maiteki‐Sebuguzi, C., Mpimbaza, A., & Opigo, J. (2025) · Malaria Journal · doi:10.1186/s12936-025-05634-w · Cited by 8
Self-citationMuhindo, R., King, R. L., Mujugira, A., Irie, W. C., Muwanguzi, P. A., Dhikusooka, F., Musaazi, J., & Castelnuovo, B. (2025) · PLOS Global Public Health · doi:10.1371/journal.pgph.0004798 · Cited by 2
Accrombessi, M., ZINSOU, C., Woolheater, K., Ghyslain, G., Wang, E., Affoukou, C. D., Chabi, Y., Satchivi, J., Hurley, C., Poyer, S., et al. (2025) · doi:10.12688/verixiv.970.1 · Cited by 1
Metadata
- Authors
- Woldeghebriel, M., Aso, E., Berlin, E., Fashanu, C., Kirumira, S. N., Lam, F., Mugerwa, R., Nakiganda, J., Olaleye, T., Opigo, J., Osinupebi, F., Priestley, N., Stringham, R., Uhomoibhi, P., Visser, T., Ward, A., Wiwa, O., & Woolsey, A.
- Affiliations
- Clinton Health Access Initiative (US)
- Ministry of Health (UG)
- Virginia Commonwealth University (US)
- Federal Ministry of Health (NG)
- Corresponding author
- Woldeghebriel, Meley
- ORCID
- Venue
- Malaria Journal
- Published
- 2024-02-06
- Volume
- 23
- Issue
- 1
- Pages
- 41-41
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC10848491
- OpenAlex
- W4391564914
- Cited by
- 9
- References
- 21
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 1
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Foreign Commonwealth and Development Office (FCDO) of the UK Government
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pharmaceutical Quality and Counterfeiting
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Keywords
- artemisinin-based combination therapy, malaria rapid diagnostic tests, Affordable Medicines Facility-malaria, drug subsidies, drug availability, drug prices, market share, malaria treatment, Nigeria, Uganda, drug policy evaluation
- MeSH terms
- Antimalarials, Humans, Malaria, Nigeria, Uganda, Private Sector, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.